Ubs Group Ag Tandem Diabetes Care Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Ubs Group Ag holds 2,745,312 shares of TNDM stock, worth $56.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,745,312

Previous 2,745,312 -0.0%

Holding current value

$56.6 Million

Previous $116 Million 15.05%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$27.34 - $41.78 $11 Million - $16.7 Million	400,868 Added 177.78%	626,350 $22.6 Million
Q3 2024 Nov 14, 2024	SELL	$35.21 - $47.3 $2.48 Million - $3.33 Million	-70,305 Reduced 23.77%	225,482 $9.56 Million
Q2 2024 Aug 13, 2024	BUY	$30.43 - $53.43 $7.76 Million - $13.6 Million	255,065 Added 626.36%	295,787 $11.9 Million
Q1 2024 May 13, 2024	BUY	$22.09 - $35.41 $210,959 - $338,165	9,550 Added 30.64%	40,722 $1.44 Million
Q4 2023 Feb 09, 2024	SELL	$14.28 - $31.03 $23,447 - $50,951	-1,642 Reduced 5.0%	31,172 $922,000
Q3 2023 Nov 09, 2023	SELL	$19.33 - $36.22 $1.89 Million - $3.54 Million	-97,783 Reduced 74.87%	32,814 $681,000
Q2 2023 Aug 11, 2023	BUY	$24.18 - $42.46 $1.5 Million - $2.64 Million	62,205 Added 90.95%	130,597 $3.2 Million
Q1 2023 May 12, 2023	BUY	$35.86 - $46.5 $1.1 Million - $1.43 Million	30,731 Added 81.6%	68,392 $2.78 Million
Q4 2022 Feb 08, 2023	SELL	$35.49 - $56.15 $968,415 - $1.53 Million	-27,287 Reduced 42.01%	37,661 $1.69 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $68.97 $2.08 Million - $3.28 Million	-47,563 Reduced 42.27%	64,948 $3.11 Million
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $10.8 Million - $25.1 Million	-203,647 Reduced 64.41%	112,511 $6.66 Million
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $9.04 Million - $13.3 Million	-88,756 Reduced 21.92%	316,158 $36.8 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $14.2 Million - $18.4 Million	119,854 Added 42.05%	404,914 $60.9 Million
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $1.16 Million - $1.61 Million	12,434 Added 4.56%	285,060 $34 Million
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $7.46 Million - $9.71 Million	-96,928 Reduced 26.23%	272,626 $26.6 Million
Q1 2021 May 12, 2021	BUY	$81.28 - $104.34 $8.99 Million - $11.5 Million	110,604 Added 42.71%	369,554 $32.6 Million
Q4 2020 Feb 11, 2021	BUY	$86.4 - $121.75 $12.9 Million - $18.1 Million	148,996 Added 135.51%	258,950 $24.8 Million
Q3 2020 Nov 12, 2020	BUY	$95.43 - $116.09 $97,529 - $118,643	1,022 Added 0.94%	109,954 $12.5 Million
Q2 2020 Jul 31, 2020	SELL	$60.05 - $98.92 $638,631 - $1.05 Million	-10,635 Reduced 8.89%	108,932 $10.8 Million
Q1 2020 May 01, 2020	BUY	$47.37 - $90.04 $508,611 - $966,759	10,737 Added 9.87%	119,567 $7.69 Million
Q4 2019 Feb 14, 2020	BUY	$53.13 - $71.19 $2.97 Million - $3.98 Million	55,872 Added 105.5%	108,830 $6.49 Million
Q3 2019 Nov 14, 2019	BUY	$57.11 - $73.3 $1.3 Million - $1.67 Million	22,823 Added 75.74%	52,958 $3.12 Million
Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $50,111 - $66,035	-921 Reduced 2.97%	30,135 $1.94 Million
Q1 2019 May 14, 2019	BUY	$32.25 - $73.56 $194,048 - $442,610	6,017 Added 24.03%	31,056 $1.97 Million
Q4 2018 Feb 14, 2019	SELL	$28.45 - $40.65 $1.51 Million - $2.15 Million	-52,971 Reduced 67.9%	25,039 $951,000
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $1.48 Million - $3.55 Million	69,393 Added 805.3%	78,010 $3.34 Million
Q2 2018 Aug 14, 2018	BUY	$4.9 - $23.64 $41,228 - $198,906	8,414 Added 4144.83%	8,617 $190,000
Q1 2018 May 15, 2018	SELL	$2.35 - $4.96 $89,351 - $188,589	-38,022 Reduced 99.47%	203 $1,000
Q4 2017 Feb 14, 2018	BUY	$2.24 - $8.2 $85,624 - $313,445	38,225	38,225 $90,000

Others Institutions Holding TNDM

# of Institutions

346

Shares Held

70.9M

Call Options Held

3.11M

Put Options Held

181K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.32B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account